81 related articles for article (PubMed ID: 10703471)
1. Differentiation of recurrent rectal cancer and scarring with dynamic MR imaging.
Dicle O; Obuz F; Cakmakci H
Br J Radiol; 1999 Dec; 72(864):1155-9. PubMed ID: 10703471
[TBL] [Abstract][Full Text] [Related]
2. [Differentiation of recurrence rectal cancer and benign pelvic lesions after curative rectal operation with 3.0 T magnetic resonance].
Wang LL; Duan Q; Xue YQ; Huang XM; Wang CS; Sun B
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Nov; 14(11):859-63. PubMed ID: 22116720
[TBL] [Abstract][Full Text] [Related]
3. [Value of 3T magnetic resonance dynamic contrast-enhanced and diffusion-weighted imaging in differential diagnosis of musculoskeletal tumors].
Qi ZH; Li CF; Ma XX; Yang H; Jiang BD; Zhang K; Yu DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Apr; 34(2):138-45. PubMed ID: 22776599
[TBL] [Abstract][Full Text] [Related]
4. Recurrent rectal cancer: diagnosis with dynamic MR imaging.
Müller-Schimpfle M; Brix G; Layer G; Schlag P; Engenhart R; Frohmuller S; Hess T; Zuna I; Semmler W; van Kaick G
Radiology; 1993 Dec; 189(3):881-9. PubMed ID: 8234720
[TBL] [Abstract][Full Text] [Related]
5. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
[TBL] [Abstract][Full Text] [Related]
6. Recurrent rectal cancer and scar: differentiation with PET and MR imaging.
Ito K; Kato T; Tadokoro M; Ishiguchi T; Oshima M; Ishigaki T; Sakuma S
Radiology; 1992 Feb; 182(2):549-52. PubMed ID: 1732979
[TBL] [Abstract][Full Text] [Related]
7. Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer.
Torricelli P; Pecchi A; Luppi G; Romagnoli R
Abdom Imaging; 2003; 28(1):19-27. PubMed ID: 12483379
[TBL] [Abstract][Full Text] [Related]
8. Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging.
Kinkel K; Ariche M; Tardivon AA; Spatz A; Castaigne D; Lhomme C; Vanel D
Radiology; 1997 Jul; 204(1):55-63. PubMed ID: 9205223
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
Dong Y; Liu Q
J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
11. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy.
Silverman JM; Krebs TL
AJR Am J Roentgenol; 1997 Feb; 168(2):379-85. PubMed ID: 9016212
[TBL] [Abstract][Full Text] [Related]
12. [MRT and dynamic CT in the diagnosis of a recurrence of rectal carcinoma].
Bachmann G; Pfeifer T; Bauer T
Rofo; 1994 Sep; 161(3):214-9. PubMed ID: 7919246
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
14. Rectal carcinoma: high-spatial-resolution MR imaging and T2 quantification in rectal cancer specimens.
Stollfuss JC; Becker K; Sendler A; Seidl S; Settles M; Auer F; Beer A; Rummeny EJ; Woertler K
Radiology; 2006 Oct; 241(1):132-41. PubMed ID: 16928975
[TBL] [Abstract][Full Text] [Related]
15. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?
Lahaye MJ; Beets GL; Engelen SM; Kessels AG; de Bruïne AP; Kwee HW; van Engelshoven JM; van de Velde CJ; Beets-Tan RG
Radiology; 2009 Jul; 252(1):81-91. PubMed ID: 19403848
[TBL] [Abstract][Full Text] [Related]
16. Preoperative 3T MR imaging of rectal cancer: local staging accuracy using a two-dimensional and three-dimensional T2-weighted turbo spin echo sequence.
Fütterer JJ; Yakar D; Strijk SP; Barentsz JO
Eur J Radiol; 2008 Jan; 65(1):66-71. PubMed ID: 18164156
[TBL] [Abstract][Full Text] [Related]
17. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy.
van Rijswijk CS; Geirnaerdt MJ; Hogendoorn PC; Taminiau AH; van Coevorden F; Zwinderman AH; Pope TL; Bloem JL
Radiology; 2004 Nov; 233(2):493-502. PubMed ID: 15459325
[TBL] [Abstract][Full Text] [Related]
18. Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging.
Kim JK; Kim SH; Jang YJ; Ahn H; Kim CS; Park H; Lee JW; Kim S; Cho KS
Radiology; 2006 Apr; 239(1):174-80. PubMed ID: 16507752
[TBL] [Abstract][Full Text] [Related]
19. The pelvis after surgery and radio-chemotherapy for rectal cancer studied with Gd-DTPA-enhanced fast dynamic MR imaging.
Blomqvist L; Fransson P; Hindmarsh T
Eur Radiol; 1998; 8(5):781-7. PubMed ID: 9601965
[TBL] [Abstract][Full Text] [Related]
20. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?
Kuhl CK; Mielcareck P; Klaschik S; Leutner C; Wardelmann E; Gieseke J; Schild HH
Radiology; 1999 Apr; 211(1):101-10. PubMed ID: 10189459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
